Announcements Trials

Browse Landscape

Phase

Phase 1 3 Phase 2 2 Phase 1/2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1 Dermatologic 1

Conditions

Colorectal Neoplasms 36 Pancreatic Neoplasms 26 Rectal Neoplasms 15 Esophageal Neoplasms 13 Colonic Neoplasms 12 Stomach Neoplasms 11 Squamous Cell Carcinoma of Head and Neck 11 Neoplasm Metastasis 8 Gastrointestinal Neoplasms 8 Esophageal Squamous Cell Carcinoma 7 Adenocarcinoma Of Esophagus 7 Neoplasms 6 Head and Neck Neoplasms 5 Carcinoma, Squamous Cell 5 Carcinoma, Non-Small-Cell Lung 5 Biliary Tract Neoplasms 5 Carcinoma, Hepatocellular 4 Advanced Solid Tumors 4 Melanoma 3 Liver Neoplasms 3 Carcinoma, Renal Cell 3 Adenocarcinoma 3 Triple Negative Breast Neoplasms 2 Parkinson Disease 4, Autosomal Dominant Lewy Body 2 Ovarian Neoplasms 2 Oropharyngeal Neoplasms 2 Kidney Neoplasms 2 Gastrointestinal Diseases 2 Endometrial Neoplasms 2 Carcinoma 2

Interventions

Gemcitabine 15 pembrolizumab 13 Doxorubicin 13 Radiotherapy 12 Docetaxel 9 Nivolumab 8 Filgrastim 7 Cyclophosphamide 7 pazopanib 6 Ifosfamide 6 130-nm albumin-bound paclitaxel 5 Temozolomide 4 Irinotecan 4 Ipilimumab 4 Imatinib Mesylate 4 Albumin-Bound Paclitaxel 4 talimogene laherparepvec 3 surufatinib 3 pegfilgrastim 3 eribulin 3 atezolizumab 3 Vinorelbine 3 Sirolimus 3 Peripheral Blood Stem Cell Transplantation 3 PM 01183 3 Drug Therapy 3 Cisplatin 3 toripalimab 2 spartalizumab 2 selinexor 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1/2 × Sarcoma × Fluorouracil × Clear all

NCT03009058 2024-11-25

MODULATE

Immodulon Therapeutics Ltd

Phase 1/2 Terminated

2 enrolled 7 charts

DermatologicSarcoma

Melanoma, Neoplasm Metastasis, Sarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡